Swahili
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Ethnic Variations in Antidepressant Response

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
Kiungo kimehifadhiwa kwenye clipboard
HaliImekamilika
Wadhamini
National Institute of Mental Health (NIMH)

Maneno muhimu

Kikemikali

This 11-week study aims to determine how genetic factors affect the way African Americans and Caucasians with major depression respond to antidepressant medication [citalopram (Celexa®)].

Maelezo

Depressed patients vary substantially in their responses to antidepressants. Genetic factors may account for a large part of these differences in response. This study will include both African Americans and Caucasians to examine the role of genetic factors in treatment response.

Participants receive citalopram (Celexa) for 8 weeks and a placebo for 1 week. Visits occur once a week for 11 weeks. A variety of interviews, scales, tests, and questionnaires are used to assess participants.

Tarehe

Imethibitishwa Mwisho: 07/31/2009
Iliyowasilishwa Kwanza: 10/10/2002
Uandikishaji uliokadiriwa Uliwasilishwa: 10/14/2002
Iliyotumwa Kwanza: 10/15/2002
Sasisho la Mwisho Liliwasilishwa: 08/02/2009
Sasisho la Mwisho Lilichapishwa: 08/03/2009
Tarehe halisi ya kuanza kwa masomo: 05/31/2002
Tarehe ya Kukamilisha Msingi iliyokadiriwa: 10/31/2006
Tarehe ya Kukamilisha Utafiti: 10/31/2006

Hali au ugonjwa

Depression

Uingiliaji / matibabu

Drug: Citalopram

Awamu

Awamu 4

Vikundi vya Arm

MkonoUingiliaji / matibabu
Active Comparator: Citalopram
All subjects receive an FDA approved dose of Citalopram
Drug: Citalopram
PDA Approved antidepressant

Vigezo vya Kustahiki

Zama zinazostahiki Kujifunza 18 Years Kwa 18 Years
Jinsia Inastahiki KujifunzaAll
Hupokea Wajitolea wa AfyaNdio
Vigezo

Inclusion Criteria:

- DSM-IV criteria for Major Depression

- African-American or Caucasian ethnic background (both parents and 3 out of 4 grandparents)

Exclusion Criteria:

- Schizophrenia, schizophreniform disorder, schizoaffective disorder, schizotypal disorder, psychotic depression, or bipolar disorder

- Current drug abuse or history of drug abuse within the past 6 months

- Unstable medical or neurological conditions that interfere with the treatment of depression

- Allergy to citalopram

- Failure to respond to adequate citalopram drug trial (40 mg for at least 6 weeks)

- Seizure disorder

- Pregnancy

- Psychotropic medications, including antidepressants and neuroleptics

- Suicidal ideation or other safety issues

- Fluoxetine (Prozac) or MAOIs (Nardil, Parnate) in the last 2 months

- Ongoing cognitive behavioral therapy or intensive psychotherapy. General talk therapy is acceptable

Matokeo

Hatua za Matokeo ya Msingi

1. Hamilton Rating Scale for Depression [Measured weekly for 11 weeks]

Jiunge na ukurasa
wetu wa facebook

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

  • Inafanya kazi katika lugha 55
  • Uponyaji wa mitishamba unaungwa mkono na sayansi
  • Kutambua mimea kwa picha
  • Ramani ya GPS inayoshirikiana
  • Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
  • Tafuta mimea ya dawa na athari zao
  • Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa

Google Play badgeApp Store badge